Clinical trial
Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib…
NCT00171977 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00171977 |
|---|---|
| Title | Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST) |
| Official title | Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST) |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastrointestinal Stromal Tumors |
| Intervention type | Drug |
| Interventions | Imatinib Mesylate |
| Enrollment | 64 |
| Start date | Jul 1, 2004 |
| Primary completion | Apr 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 7, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: